Al-Ahsa, Saudi Arabia

Yasair S Al-Faiz

This inventor holds 1 USPTO granted patent. Top assignee: King Faisal University. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasair S Al-Faiz. Retrieved from https://idiyas.com/inventor/yasair-s-al-faiz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yasair S Al-Faiz: Innovator in Anticancer Research

Introduction

Yasair S Al-Faiz is a prominent inventor based in Al-Ahsa, Saudi Arabia. He has made significant contributions to the field of organoselenium compounds, particularly in their application for cancer treatment. His innovative work focuses on developing compounds that can enhance anticancer activity.

Latest Patents

Yasair S Al-Faiz holds a patent for "Antiproliferative selenated-folate hybrids." This patent describes novel organoselenium compounds formed with folates that can be utilized to maximize the anticancer activity of organoselenium. These compounds are also recognized for their potential as chemopreventive agents against cancer. They may be incorporated into pharmaceutical compositions and used in various treatment methods.

Career Highlights

Yasair S Al-Faiz is affiliated with King Fahd University of Petroleum and Minerals, where he conducts research and develops innovative solutions in the field of cancer treatment. His work has garnered attention for its potential impact on improving therapeutic strategies against cancer.

Collaborations

Some of his notable coworkers include Amr Negm and Saad Shaaban, who contribute to the collaborative research efforts in his field.

Conclusion

Yasair S Al-Faiz is a dedicated inventor whose work in organoselenium compounds represents a significant advancement in cancer treatment. His innovative approach and commitment to research continue to pave the way for future developments in this critical area of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…